CBT is the most evidence-based psychotherapy for GAD
Response rate 46–60%; comparable to pharmacotherapy at long-term follow-up
CBT + pharmacotherapy superior to either alone for moderate-severe GAD
Internet-delivered CBT (iCBT) — comparable efficacy to face-to-face in RCTs
Scalable option for patients with access barriers
Monitoring and treatment optimization
Serial GAD-7 to track response — target at least 50% score reduction
If inadequate response after adequate trial — switch within class or augment
Minimum 12-month treatment duration to prevent relapse
Relapse risk up to 50% if discontinued before 1 year
Patient Discharge Instructions
copy discharge instructions
Discharge instructions for Generalized Anxiety Disorder
What is Generalized Anxiety Disorder?
GAD is a common, treatable medical condition characterized by persistent, excessive worry about multiple areas of life
Symptoms include restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep difficulties
Physical symptoms such as headaches, stomach upset, and muscle pain are very common
GAD responds well to treatment — most people improve significantly with appropriate care
Your medications
Take your prescribed medication every day as directed — do not skip doses
Anxiety medications take 2–4 weeks to begin working; full benefit may take 2–3 months
Early side effects (nausea, jitteriness, sleep changes) are common and usually improve within 2 weeks
Do not stop your medication abruptly — always taper under your doctor's guidance
Avoid alcohol — it worsens anxiety in the long run and interacts with your medications
Reduce or eliminate caffeine — it can significantly worsen anxiety symptoms
Lifestyle recommendations
Regular aerobic exercise at least 3–5 times per week has proven anxiolytic benefit
Maintain consistent sleep schedule — go to bed and wake at the same time daily
Practice diaphragmatic breathing: breathe in for 4 seconds, hold 2, out for 6 seconds
Reduce screen time before bed — aim for a device-free hour before sleep
Reach out to a counselor or therapist for CBT — the most effective anxiety therapy
Follow-up instructions
Follow up with your doctor in 2–4 weeks after starting or changing medication
If you cannot get an appointment quickly, call your doctor if side effects are troublesome
Consider asking your doctor for a referral to a therapist specializing in cognitive behavioral therapy
Return to emergency department if any of the following occur
Thoughts of harming yourself or others — call 988 (Suicide and Crisis Lifeline) or go to nearest ED immediately
Severe chest pain, difficulty breathing, or heart racing that does not settle within minutes
Fainting or loss of consciousness
Sudden severe headache unlike any previous headache
New weakness, numbness, vision changes, or speech difficulty
Medication side effects: severe nausea or vomiting, high fever with muscle stiffness (serotonin syndrome), severe skin rash
Worsening anxiety or new panic attacks that prevent you from functioning
References
Guidelines and key sources
Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)
American Psychiatric Association, 2013 (updated 2022)
Diagnostic criteria for GAD: ≥6 months of excessive worry, difficult to control, with ≥3 of 6 associated symptoms
ICD-10 code: F41.1 — Generalized Anxiety Disorder
Stein MB, Sareen J. Generalized Anxiety Disorder. New England Journal of Medicine. 2015
Comprehensive clinical review with treatment algorithm
SSRI/SNRI first-line; CBT equivalent efficacy to pharmacotherapy
Minimum 12-month treatment to prevent relapse
Szuhany KL, Simon NM. Anxiety Disorders: A Review. JAMA. 2022
Updated treatment evidence review
Combined CBT plus pharmacotherapy superior to either alone for moderate-severe GAD
Intolerance of uncertainty model evidence base
Shepardson RL et al. Treatment of Anxiety for Adults in Primary Care Settings. JAMA Internal Medicine. 2026
Clinical algorithm for anxiety management in primary care
Quetiapine efficacious but poorly tolerated — not first-line
Bupropion and vortioxetine inconsistent evidence — not recommended
Slee A et al. Pharmacological Treatments for Generalised Anxiety Disorder: Systematic Review and Network Meta-Analysis. Lancet. 2019
Network meta-analysis of pharmacotherapy options
Escitalopram, duloxetine, venlafaxine among most effective options
Benzodiazepines effective short-term but long-term harms outweigh benefits
US Preventive Services Task Force. Screening for Anxiety Disorders in Adults. JAMA. 2023
USPSTF recommends screening adults under 65 for anxiety disorders
GAD-7 recommended as primary screening tool
Insufficient evidence for screening adults 65 and older
Walter HJ et al. Clinical Practice Guideline for Assessment and Treatment of Children and Adolescents with Anxiety Disorders. JAACAP. 2020
Pediatric anxiety treatment guidelines
CBT first-line; SSRI for moderate-severe; combined superior to either alone
Black box warning for SSRI-related suicidal ideation in pediatric patients
DeGeorge KC et al. Generalized Anxiety Disorder and Panic Disorder in Adults. American Family Physician. 2022
Primary care management reference
Buspirone no dependence risk; useful alternative to benzodiazepines
Parental GAD hazard ratio 3.77 for offspring GAD
Penninx BW et al. Anxiety Disorders. Lancet. 2021
Epidemiology and pathophysiology review
Lifetime prevalence approximately 9% globally
Neurobiological amygdala-prefrontal circuit dysfunction model
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.